Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Frailty Prevention Program to Prevent Frailty Among Older African Americans (FPP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03585972
Recruitment Status : Recruiting
First Posted : July 13, 2018
Last Update Posted : July 19, 2018
Sponsor:
Collaborator:
Michigan Health Endowment Fund
Information provided by (Responsible Party):
Heather Fritz, Wayne State University

Brief Summary:
Between 20-60% of older adults experience frailty as they age. Frailty is a clinical state of increased vulnerability resulting from aging-associated declines in biological reserve across multiple physiologic systems. Because of the lack of biological reserve, relatively minor physical or psychological assaults have the potential to trigger a cascade of negative sequelae for frail older adults resulting in adverse health outcomes including mortality, disability in basic and instrumental activities of daily living, hospitalization and emergency visits, and institutionalization in community-dwelling older adults. Despite the potential personal and economic consequences of frailty syndrome, frailty is not an irreversible process. For example, a 4.5-year longitudinal study conducted by Gill et al., (2006) demonstrated that of their 754 community dwelling older adults, 58% had at least one change in frailty status during the study period and that approximately one third of these transitions were from a state of greater frailty to one of lesser frailty, suggesting that it is possible to reverse the frailty trajectory. Nonetheless, there is a lack effective means of reversing frailty or slowing the progression of older adults along the frailty continuum.The purpose of the proposed research is to evaluate the feasibility and preliminary effectiveness of an occupational therapy intervention delivered through the primary care setting for improving frailty status and physical functioning among older adults ages 55 and older who are pre-frail when compared to usual care.

Condition or disease Intervention/treatment Phase
Frail Elderly Syndrome Behavioral: Frailty Prevention Program Not Applicable

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 150 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Masking Description: Outcome assessors do not know which arm participants were assigned to.
Primary Purpose: Prevention
Official Title: Occupational Therapy Services to Improve Frailty Status
Actual Study Start Date : May 5, 2018
Estimated Primary Completion Date : November 1, 2019
Estimated Study Completion Date : February 1, 2020

Arm Intervention/treatment
Experimental: Frailty Prevention Program
4 face-to-face sessions, with a licensed and registered occupational therapist over 4 months
Behavioral: Frailty Prevention Program
4 face-to-face sessions, with a occupational therapist over 4 months to address function, safety, social participation, diet, exercise, sleep, and medication management. Sessions are expected to last between 60-120 minutes. The first session is a comprehensive occupational therapy evaluation and treatment plan. Sessions 2 and 3 involved physical activity and dietary education, counseling and goal setting. Session 4 involves reviewing program progress, and setting maintenance goals.

No Intervention: Educational materials
Participants receive publicly available educational materials



Primary Outcome Measures :
  1. Frailty [ Time Frame: From week 0 to week 16 ]
    Fried Frailty Index


Secondary Outcome Measures :
  1. Self Rate Quality of Life [ Time Frame: From week 0 to week 16 ]
    WHOQOL BREF (brief version)

  2. Social Participation [ Time Frame: From week 0 to week 16 ]
    NIH PROMISE Ability to Participate & Satisfaction with Social Roles (Short forms 8a)

  3. Global Health [ Time Frame: From week 0 to week 16 ]
    NIH PROMISE Global Health form

  4. Health Service Utilization [ Time Frame: From week 0 to week 40 ]
    Narrative self-report of services



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   55 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Prefrail (meeting 1-2 of the following 5 criteria: self-report of loss of at least 10% of body weight over a 2-year period and the four following questions: (1) "Because of health problems, do you have any difficulty with lifting or carrying weights over 10 pounds, like a heavy bag of groceries?", (2) "Because of a health problem, do you have any difficulty with getting up from a chair after sitting for long periods?", (3) "Have you had any of the following persistent or troublesome problems: severe fatigue or exhaustion?", and (4) "Have you fallen down in the past 2 years?" )
  • African American
  • Age 55 and older

Exclusion Criteria:

  • Moderate to severe dementia
  • A serious physical disability that requires a caregiver to provide care for basic activities of daily living
  • A terminal illness (e.g., end stage renal disease or end stage cancer).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03585972


Contacts
Layout table for location contacts
Contact: Heather Fritz, PhD 313-577-9499 heather.fritz@wayne.edu
Contact: Chen Almacen, BS 3139939932 calmacen@med.wayn.edu

Locations
Layout table for location information
United States, Michigan
Wayne State University Recruiting
Detroit, Michigan, United States, 48201
Contact: Heather Fritz, PhD    313-577-9499    heather.fritz@wayne.edu   
Principal Investigator: Heather Fritz, PhD         
Sponsors and Collaborators
Wayne State University
Michigan Health Endowment Fund
Investigators
Layout table for investigator information
Principal Investigator: Heather Fritz, PhD Wayne State University

Layout table for additonal information
Responsible Party: Heather Fritz, Assistant Professor of Occupational Therapy and Gerontology, Wayne State University
ClinicalTrials.gov Identifier: NCT03585972     History of Changes
Other Study ID Numbers: 1701000204
First Posted: July 13, 2018    Key Record Dates
Last Update Posted: July 19, 2018
Last Verified: July 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Frailty
Pathologic Processes